| [1] |
Emond JC, Renz JF, Ferrell LD, et al. Functional analysis of grafts from living donors. implications for the treatment of older recipients[J]. Ann Surg,1996,224(4):544-554. doi: 10.1097/00000658-199610000-00012
|
| [2] |
Chan SC, Lo CM, Chok KS, et al. Validation of graft and standard liver size predictions in right liver living donor liver transplantation[J]. Hepatol Int,2011,55(4):913-917. doi: 10.1016/j.jhep.2011.01.030
|
| [3] |
Morioka D, Egawa H, Kasahara M, et al. Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases[J]. Ann Surg,2007,245(2):315-325. doi: 10.1097/01.sla.0000236600.24667.a4
|
| [4] |
Wakade VA, Mathur SK. Donor safety in live-related liver transplantation[J]. Indian J Surg,2012,74(1):118-126. doi: 10.1007/s12262-011-0385-4
|
| [5] |
Tanaka K, Yamada T. Living donor liver transplantation in Japan and Kyoto University: what can we learn?[J]. J Hepatol,2005,42(1):25-28. doi: 10.1016/j.jhep.2004.11.004
|
| [6] |
Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications[J]. Am J Transplant,2005,5(11):2605-2610. doi: 10.1111/ajt.2005.5.issue-11
|
| [7] |
Jiménez-Romero C, Clemares-Lama M, Manrique-Municio A, et al. Long-term results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years[J]. World J Surg,2013,37(9):2211-2221. doi: 10.1007/s00268-013-2085-7
|
| [8] |
Nocito A, El-Badry AM, Clavien PA. When is steatosis too much for transplantation?[J]. J Hepatol,2006,45(4):494-499. doi: 10.1016/j.jhep.2006.07.017
|
| [9] |
Wu TJ, Dahiya D, Lee CS, et al. Impact of portal venous hemodynamics on indices of liver function and graft regeneration after right lobe living donor liver transplantation[J]. Liver Transpl,2011,17(9):1035-1045. http://cn.bing.com/academic/profile?id=1973976111&encoded=0&v=paper_preview&mkt=zh-cn
|
| [10] |
Campos BD, Botha JF. Strategies to optimize donor safety with smaller grafts for adult-to-adult living donor liver transplantation[J]. Curr Opin Organ Transplant,2012,17(3):230-234. http://cn.bing.com/academic/profile?id=1991487145&encoded=0&v=paper_preview&mkt=zh-cn
|
| [11] |
Ho H, Sorrell K, Bartlett A, et al. Modeling the hepatic arterial buffer response in the liver[J]. Med Eng Phys,2013,35(8):1053-1058. doi: 10.1016/j.medengphy.2012.10.008
|
| [12] |
Asencio JM, Vaquero J, Olmedilla L, et al. "Small-for-flow" syndrome: shifting the "size" paradigm[J]. Med Hypotheses,2013,80(5):573-577. doi: 10.1016/j.mehy.2013.01.028
|
| [13] |
Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited[J]. World J Gastroenterol,2010,16(48):6046-6057. doi: 10.3748/wjg.v16.i48.6046
|
| [14] |
Kostopanagiotou G, Pandazi A, Arkadopoulos N, et al. Norepinephrine in small-for-size liver grafts: an experimental study in pigs[J]. J Surg Res,2007,141(2):257-261. doi: 10.1016/j.jss.2006.11.005
|
| [15] |
Suehiro T, Shimada M, Kishikawa K, et al. Impact of graft hepatic vein inferior vena cava reconstruction with graft venoplasty and inferior vena cava cavoplasty in living donor adult liver transplantation using a left lobe graft[J]. Transplantation,2005,80(7):964-968. doi: 10.1097/01.tp.0000173776.66867.f5
|
| [16] |
Li H, Li B. Using small-for-size grafts in living donor liver transplantation recipients with high meld scores should not be considered a contraindication[J]. Dig Dis Sci,2013,58(11):3374-3375. doi: 10.1007/s10620-013-2797-4
|
| [17] |
Yamada T, Tanaka K, Uryuhara K, et al. Selective hemi-portocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation[J]. Am J Transplant,2008,8(4):847-853. doi: 10.1111/ajt.2008.8.issue-4
|
| [18] |
Lee S, Hwang S, Park K, et al. An adult-to-adult living donor liver transplant using dual left lobe grafts[J]. Surgery,2001,129(5):647-650. doi: 10.1067/msy.2001.114218
|
| [19] |
Kasahara M, Takada Y, Egawa H, et al. Auxiliary partial orthotopic living donor liver transplantation: Kyoto University experience[J]. Am J Transplant,2005,5(3):558-565. doi: 10.1111/ajt.2005.5.issue-3
|
| [20] |
Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation[J]. Liver Transpl,2003,9(7):651-663. doi: 10.1053/jlts.2003.50105
|
| [21] |
Hayashi M, Fujii K, Kiuchi T, et al. Effects of fatty infiltration of the graft on the outcome of living-related liver transplantation[J]. Transplant Proc,1999,31(1/2):403. http://cn.bing.com/academic/profile?id=2108093520&encoded=0&v=paper_preview&mkt=zh-cn
|
| [22] |
Yamamoto K, Takada Y, Fujimoto Y, et al. Nonalcoholic steatohepatitis in donors for living donor liver transplantation[J]. Transplantation,2007,83(3):257-262. doi: 10.1097/01.tp.0000250671.06456.3f
|
| [23] |
Nakamuta M, Morizono S, Soejima Y, et al. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation[J]. Transplantation,2005,80(5):608-612. doi: 10.1097/01.tp.0000166009.77444.f3
|
| [24] |
Troisi R, Cammu G, Militerno G, et al. Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation?[J]. Ann Surg,2003,237(3):429-436. http://cn.bing.com/academic/profile?id=2058654679&encoded=0&v=paper_preview&mkt=zh-cn
|
| [25] |
Umeda Y, Yagi T, Sadamori H, et al. Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft[J]. Transplantation,2008,86(5):673-680. doi: 10.1097/TP.0b013e318181e02d
|
| [26] |
Li DW, Du CY, Fan B, et al. Impact of simultaneous splenectomy and orthotopic liver transplantation in patients with end-stage liver diseases and splenic hyperfunction[J]. Hepatobiliary Pancreat Dis Int,2012,11(5):489-493. doi: 10.1016/S1499-3872(12)60212-4
|
| [27] |
Boillot O, Delafosse B, Méchet I, et al. Small-for-size partial liver graft in an adult recipient; a new transplant technique[J]. Lancet,2002,359(9304):406-407. doi: 10.1016/S0140-6736(02)07593-1
|
| [28] |
Troisi R, Ricciardi S, Smeets P, et al. Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation[J]. Am J Transplant,2005,5(6):1397-1404. doi: 10.1111/ajt.2005.5.issue-6
|
| [29] |
Sánchez-Cabús S, Fondevila C, Calatayud D, et al. Importance of the temporary portocaval shunt during adult living donor liver transplantation[J]. Liver Transpl,2013,19(2):174-183. doi: 10.1002/lt.23558
|
| [30] |
Saner F, Sotiropoulos GC, Radtke A, et al. Small-for-size syndrome after living-donor liver transplantation treated by "portal vein wrapping" and single plasmapheresis[J]. Transplantation,2005,79(5):625. doi: 10.1097/01.TP.0000148911.32322.87
|
| [31] |
Sato Y, Yamamoto S, Takeishi T, et al. Inferior mesenteric venous left renal vein shunting for decompression of excessive portal hypertension in adult living related liver transplantation[J]. Transplant Proc,2004,36(8):2234-2236. doi: 10.1016/j.transproceed.2004.08.027
|
| [32] |
Ikegami T, Soejima Y, Taketomi A, et al. Explanted portal vein grafts for middle hepatic vein tributaries in living-donor liver transplantation[J]. Transplantation,2007,84(7):836-841. doi: 10.1097/01.tp.0000296483.89112.4c
|
| [33] |
Man K, Lee TK, Liang TB, et al. FK 409 ameliorates small-for-size liver graft injury by attenuation of portal hypertension and down-regulation of Egr-1 pathway[J]. Ann Surg,2004,240(1):159-168. doi: 10.1097/01.sla.0000129673.13552.c0
|
| [34] |
Liu Y, Jiang J, Xiao H, et al. Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice[J]. Mol Vis,2012,18:624-633. http://cn.bing.com/academic/profile?id=1485770768&encoded=0&v=paper_preview&mkt=zh-cn
|
| [35] |
Xu X, Man K, Zheng SS, et al. Attenuation of acute phase shear stress by somatostatin improves small-for-size liver graft survival[J]. Liver Transpl,2006,12(4):621-627. doi: 10.1002/(ISSN)1527-6473
|
| [36] |
Ozden I, Kara M, Pinarbasi B, et al. Somatostatin and propranolol to treat small-for-size syndrome that occurred despite splenic artery ligation[J]. Exp Clin Transplant,2007,5(2):686-689. http://cn.bing.com/academic/profile?id=2411191922&encoded=0&v=paper_preview&mkt=zh-cn
|
| [37] |
Yamanaka K, Hatano E, Iguchi K, et al. Effect of olprinone on liver microstructure in rat partial liver transplantation[J]. J Surg Res,2013,183(1):391-396. doi: 10.1016/j.jss.2012.11.033
|
| [38] |
Suehiro T, Shimada M, Kishikawa K, et al. Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantation[J]. Transpl Int,2005,18(8):923-928. doi: 10.1111/tri.2005.18.issue-8
|
| [39] |
Yu Y, Yao AH, Chen N, et al. Mesenchymal stem cells over-expressing hepatocyte growth factor improve small-for-size liver grafts regeneration[J]. Mol Ther,2007,15(7):1382-1389. doi: 10.1038/sj.mt.6300202
|
| [40] |
Mori H, Shinohara H, Arakawa Y, et al. Beneficial effects of hyperbaric oxygen pretreatment on massive hepatectomy model in rats[J]. Transplantation,2007,84(12):1656-1661. doi: 10.1097/01.tp.0000291778.86758.1d
|
| [41] |
Sotiropoulos GC, Lang H, Herget-Rosenthal S, et al. Salvage plasmapheresis for small-for-size syndrome following hepatic resection for colorectal liver metastases[J]. Int J Colorectal Dis,2008,23(5):553. doi: 10.1007/s00384-007-0405-9
|
点击查看大图
下载:
